Skip to main content

VCYT

Stock
Health Care
Diagnostics & Research

Performance overview

VCYT Price
Price Chart

Forward-looking statistics

Beta
1.72
Risk
55.66%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

Veracyte Inc is a genomic diagnostics company. It provides genomic diagnostic products and services to improve patient care against diseases such as thyroid cancer, lung cancer, and idiopathic pulmonary fibrosis. The firm's product portfolio consists of products such as Afirma analysis, Percepta, Envisia, and others.

Company info

SectorHealth Care
IndustryDiagnostics & Research
Employees686
Market cap$1.6B

Fundamentals

Enterprise value$1.9B
Revenue$463.4M
Revenue per employee—
Profit margin7.13%
Debt to equity4.23

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)$0.42
Dividend per share—
Revenue per share$6.00
Avg trading volume (30 day)$25M
Avg trading volume (10 day)$29M
Put-call ratio—

Macro factor sensitivity

Growth-0.8
Credit+8.9
Liquidity+0.3
Inflation-6.8
Commodities-0.4
Interest Rates-2.7

Valuation

Dividend yield0.00%
PEG Ratio68.78
Price to sales4.65
P/E Ratio68.78
Enterprise Value to Revenue4.06
Price to book1.80

Upcoming events

Next earnings dayMay 8, 2025
Next dividend day—
Ex. dividend day—

News

Veracyte Stock Surges 30.9% in a Year: What's Driving the Rally?

Strength in VCYT's Afirma and Decipher tests continues to draw investors' attention.

Zacks Investment Research (May 19, 2025)
Diagnostic Company Veracyte Weighs Sale For French Subsidiary, Analyst Says 'Walking Away' Is A Long-Term Positive

On Monday, Veracyte Inc VCYT reported adjusted earnings of 36 cents. That's up from 21 cents a year ago, beating the consensus of 11 cents.

Benzinga (February 25, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free